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Summary  Reconstruction  of  bone  defects  prior  to  implant  placement  now  involves  synthetic
substitutes  such  as  -TCP  because  of  its  ability  to  promote  bone  remodeling.  Its  capacity  to
be progressively  substituted  by  the  patient’s  bone  allows  to  regenerate  a  dense  bone  volume.
In addition,  its  availability  in  large  quantities,  avoiding  the  morbidity  observed  with  harvest-
ing autogenous  bone,  widens  the  operative  indications.  In  this  paper,  the  main  indications
of -TCP  in  maxillofacial  surgery  (dentistry,  parodontology  and  dental  implant  surgery)  are
reviewed. They  include  periodontal  bone  disease,  bone  disjunction,  pre-implant  surgery  (sinus
ﬂoor elevation  and  lateralization  of  the  inferior  alveolar  nerve).
© 2017  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  La  reconstruction  des  déﬁcits  osseux  avant  la  pose  d’implant  fait  appel  désormais  à
des matériaux  de  substitution  synthétique  comme  le  -TCP  de  par  ses  capacités  à  favoriser  le
remodelage  osseux.  Il  est  progressivement  substitué  par  l’os  du  patient  permettant  de  régénérer
un volume  osseux  dense.  Enﬁn,  sa  disponibilité  en  grande  quantité,  évitant  la  morbidité  liée
à un  site  de  prélèvement  d’autogreffe,  élargit  les  indications  opératoires.  Dans  ce  travail,
les principales  indications  d’utilisation  du  -TCP  en  chirurgie  maxillofaciale  (chirurgie  den-Sinus  lift  ;
Tri  calcium  phosphate taire, parodontologie  et  implantation  dentaire)  sont  revues.  Elles  comprennent  la  maladie
osseuse  parodontale,  la  disjonction  osseuse,  la  chirurgie  pré-implantaire  (élévation  de  sinus
et latéralisation  du  nerf  alvéola
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n  dental  and  maxillofacial  surgery,  the  repair  of  bone
efects  aims  at  recreating  a  bony  site  that  is  suitable  for
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Figure  1  Scanning  electron  microscopic  image  of  beta-
tricalcium  phosphate  (-TCP).  A.  A  scaffold  suitable  for  bone
grafting with  an  interconnected  macroporosity.  B.  High  magni-
ﬁ
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graft  depend  on  the  volumes  to  be  ﬁlled  (alveolar  area)  or  to
be  restored  (vertical  or  horizontal  ridge  insufﬁciency,  bone
cyst  or  sinus  lifting).  The  volume  and  form  of  the  defect
inﬂuence  the  choice  of  the  grafting  material.  A  consider-
able  number  of  possibilities  are  available:  e.g.,  harvesting
autologous  bone  particles  to  ﬁll  a  post-extraction  socket  [3],
thickening  of  a  thin  ridge  caused  by  hypodontia  [4],  bone  dis-
junction  [5], sinus  lifting  [6]  or  lateralization  of  the  inferior
alveolar  nerve  [7].  Surgical  techniques  also  use  various  sur-
gical  protocols  with  a  local  or  a  general  anesthesia;  it  should
be  noticed  that  local  anesthesia  is  being  practiced  more  and
more  frequently.  Although  autologous  bone  grafts  and  allo-
grafts  have  been  a recognized  surgical  modality  for  several
decades,  the  use  of  synthetic  biomaterials  has  continued  to
develop  as  substitute  products,  especially  in  the  context  of
pre-implant  surgery.
Deﬁnitions of graft-related criteria
A  bone  substitute  must  be  biocompatible  and  ﬁll  several
criteria:  bio-inertia  is  deﬁned  as  the  absence  of  physico-
chemical  reaction  of  the  product  in  direct  contact  with
bone.  Bioactivity  is  the  capacity  to  develop  reactions  favor-
ing  osseointegration  of  the  product  and  the  adaptation  of  thecation  of  the  surface  of  a  wall  of  this  scaffold  showing  the
ypical surface  of  sintered  grains  with  microporosity  (arrows).
orphological,  prosthetic  or  implant-prosthetic  rehabilita-
ion  [1,2].  Causes  of  bone  deﬁciency  are  numerous:  genetic,
ost-traumatic,  secondary  to  tooth  removal,  infectious  or
atrogenic.  The  volume  of  bone  to  reconstruct  varies  accord-
ng  to  the  anatomical  situation.  The  characteristics  of  the
igure  2  Filling  a  bone  socket  and  reconstruction  of  the  corti-
al side  with  beta-tricalcium  phosphate  (-TCP)  granules  after
 tooth  extraction.  Insert:  CT  analysis  of  the  reconstructed  bone
everal months  after  the  graft,  note  the  high  bone  density.
Figure  3  A.  Disjunction  on  a  premolar  zone.  B.  Beta-
tricalcium  phosphate  (-TCP)  granules  (1000—2000  m)  with
high porosity  are  inserted  in  the  gap  created  between  the  two
cortices.
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it  a  reliable  material  particularly  adapted  to  ﬁll  alveolarBone  ﬁlling  with  -TCP  
receiving  tissue.  Osteoinduction  is  deﬁned  as  the  ability  to
induce  bone  formation  in  an  extra-skeletal  area.  Osteocon-
duction  is  the  ability  of  the  recipient  bone  cells  to  colonize
the  graft.  An  evolution  in  the  choice  of  materials  to  ﬁll  bone
defects  occurred  in  the  past  few  years.  Autologous  graft  is
considered  as  the  ‘‘gold  standard’’  in  terms  of  osteogenic-
ity  but  its  main  disadvantage  is  that  obtaining  a  sufﬁcient
volume  of  bone  is  sometimes  a  problem  (except  when  large
bone  samples  are  harvested  but  with  a  signiﬁcant  increase
in  morbidity)  [8,9].  So,  due  to  the  justiﬁed  reluctance  to  use
extra-oral  bone  grafts  and  the  medicolegal  constraints,  the
interest  for  synthetic  bone  substitutes  is  increasingly  grow-
ing.  Most  surgical  teams  seek  to  restore  sufﬁcient  amounts
of  high  quality  bone  allowing  implant  placement  by  using
biomaterials  to  restore  a  part  or  the  whole  bone.  Beta-
tricalcium  phosphate  (-TCP)  is  now  one  of  the  most  used
synthetic  materials  for  bone  reconstruction  in  orthopedic
and  maxillofacial  surgery  and  now  in  pre-implant  surgery.
In  implantology,  the  resorbable  or  non-resorbable  nature
of  the  grafted  material  appears  of  the  upmost  importance.
Some  materials  are  resorbable  but  there  are  considerable
differences  in  term  of  disappearance  upon  time,  some  of
them  can  persist  indeﬁnitely.  The  use  of  a  biomaterial  in  a
maxillary  or  mandibular  site  after  a  tooth  extraction  must
allow  implant  placement  in  a  second  surgical  time.  In  addi-
tion,  synthetic  biomaterials  preserve  the  macroarchitecture
s
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Figure  4  Sinus  lift  elevation.  A.  The  sinus  membrane  is  gently  pus
C. Beta-tricalcium  phosphate  (-TCP)  granules  (1000—2000  m)  with
placed in  the  grafted  area  9  months  later,  note  the  increase  density115
f  the  implanted  areas  and  they  can  be  produced  in  large
uantities  by  industry.
haracteristics of -TCP
-TCP  -  Ca3(POH4)2 - belongs  to  the  family  of  tricalcium
hosphates  in  the  beta  phase.  Being  considerably  much  more
esorbable  than  hydroxyapatite,  this  biomaterial  is  highly
iocompatible  when  implanted  in  bone;  it  is  resorbable
ithin  6  to  9  months  as  shown  in  animal  and  human  his-
ological  studies  [10]. One  of  the  main  characteristics  of
he  biomaterial  is  to  be  commercially  available  as  scaf-
olds  with  a macroporosity  of  100  to  600  m  that  ensures
steoconduction  and  can  reach  85%  of  the  total  mass  of  the
rafted  material  (Fig.  1A).  -TCP  has  also  a  microporosity
<  100  m)  due  to  sintering  of  elementary  grains,  which  facil-
tates  the  exchange  of  extracellular  ﬂuxes  of  Ca2+ and  PO43−
ons  (Fig.  1B).  This  ensures  an  optimal  bone  remodeling
ith  increased  osteoblastic  apposition  and  the  apposition
f  lamellar  bone.  Its  biocompatibility,  its  bioresorption  and
steoconductive  properties  from  the  recipient  bone  makeockets  of  variable  sizes.  In  addition,  reconstruction  of  a
axillary  sinus  in  a  pre-implantation  step  can  also  be  easily
btained.  -TCP  can  also  be  prepared  in  the  form  of  plates
hed  away.  B.  The  space  available  for  grafting  is  then  exposed.
 a  high  porosity  are  used  to  ﬁll  this  area.  D.  Implants  have  been
 of  the  grafted  zone.
116  
to  ﬁll  the  sinus  ceiling.  Such  plates  also  allow  to  densify  the
underlying  graft  with  granules  and  can  be  used  to  protect  the
sinus  mucosa  (Schneider’s  membrane)  in  case  of  perforation.
Clinical indications of bone ﬁlling biomaterials
Periodontics  and  pre-implant  surgery
Periodontal  bone  disease
It  has  been  proposed  for  more  than  15  years  to  ﬁll  peri-
odontal  pockets  with  biomaterial  granules.  Loss  of  the
peri-radicular  bone  tissue  induces  mobility  of  the  dental  root
and  can  cause  loss  of  the  tooth.  Under  local  anesthesia,  the
procedure  consists  in  detaching  the  full  thickness  of  the  gin-
giva  to  scrap  the  inﬂammatory  tissues  and  cementum  along
the  root  and  to  ﬁll  the  defect.  -TCP  is  available  in  various
granule  sizes  varying  from  550—1000  m  to  1000—2000  m.
Figure  5  Histological  analysis  of  a  bone  biopsy  harvested
in a  patient  six  months  after  grafting  with  beta-tricalcium
phosphate  (-TCP)  granules.  A.  Mineralized  bone  is  apposed
directly  onto  the  biomaterial  surfaces.  (Goldner’s  trichrome,
calciﬁed  bone  is  in  green  osteoid  tissue  in  red).  B.  Remodel-
ing of  implanted  -TCP  granules  by  osteoclasts.  Histoenzymatic
identiﬁcation  of  these  cells  by  their  tartrate  resistant  acid
phosphatase  (TRAcP)  content;  osteoclasts  are  in  brown,  newly-
apposed  bone  is  counterstained  in  blue  and  -TCP  remains
unstained.
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he  characteristics  of  -TCP  scaffolds  prepared  with  a  high
orosity  by  industry  are  to  promote  reconstruction  with
amellar  bone.  In  case  of  apicoectomy  and  elimination  of
he  cystic  tissues  at  the  apex  of  the  tooth,  a  bone  loss  may
ccur  with  a  variable  volume  ranging  from  a  few  mm3 to  1
r  2  cm3. The  cystic  tissue  is  removed  by  a careful  curettage
nd  1000—2000  m  granules  of  high  porosity  -TCP  are  used
o  ﬁll  the  cavity.
re-implant  surgery
ncreasing  the  volume  of  the  dental  arch  will  allow  the
lacement  of  dental  implants.  In  implant  surgery,  it  is  often
andatory  to  respect  the  healing  time  necessary  for  the
rafted  area  to  be  remodeled  before  placing  an  implant  in
 bone  environment  that  is  sufﬁcient  in  volume  and  will
emain  stable  over  time.  Post-extraction  sockets,  as  peri-
dontal  pockets,  can  beneﬁt  from  the  use  of  -TCP  granules
o  support  bone  reconstruction  (Fig.  2).
one  disjunction
hether  at  the  maxilla  or  the  mandible,  insufﬁcient  thick-
ess  of  the  ridge  imposes  to  recreate  the  bone  thickness.
pposition  graft  is  an  alternative  technique  but  requires  a
econd  site  to  harvest  the  autogenous  bone;  sometimes  this
s  not  possible  or  rejected  by  the  patient.  Bone  disjunction
epresents  in  fact  a greenstick  fracture  [11].  With  a  bone
hisel  or  with  a  ﬁssure  burr,  vertical  sections  are  done  at  the
esired  height  (Fig.  3A).  Similarly,  a  cleavage  plane  is  made
n  the  whole  thickness  of  the  ridge.  Finally,  the  cortical  bone
s  gradually  moved  away  while  maintaining  its  apical  inser-
ion.  The  gap  (4  to  5  mm  in  thickness)  is  then  ﬁlled  with
-TCP  1000—2000  m  granules,  this  prevents  the  vestibular
ortical  bone  from  returning  in  place  (Fig.  3B).  This  allows
one  remodeling  and  osseointegration  of  the  biomaterial  by
steoconduction  in  8  to  9  months.
inus  ﬂoor  elevation
lacement  of  an  implant  in  the  posterior  zone  of  the  upper
aw  is  often  challenging  because  bone  loss  is  observed  in
ost  patients  with  edentulation  and  thickness  of  the  sinus
oor  may  be  reduced  up  to  5  to  6  mm.  It  is  evident  that
uch  a  reduced  vertical  bone  height  limits  implant  place-
ent  since  an  8  to  10  mm  of  bone  height  is  required  to  allow
mplant  placement.  Thus,  elevation  of  the  maxillary  sinus
oor  is  a  recently  described  solution  to  restore  a  suitable  5
o  10  mm  height  of  available  bone  for  implant  placement.
inus  lifting  was  ﬁrst  reported  by  Boyne  and  James  in  the
960s  [12]. Sinus  ﬂoor  elevation  for  dental  implant  place-
ent  is  obtained  by  detachment  of  the  sinus  mucosa  using
 lateral  maxillary  window  approach  (lateral  anthrotomy,  in
ost  cases)  or  by  the  crestal  route,  followed  by  the  ﬁlling  by
 grafting  material  [13—15].  A  crestal  incision  of  the  max-
lla  is  made  on  the  alveolar  ridge  with  a  vertical  discharge
ncision  in  the  canine  region  and  opposite  to  the  posterior
uberosity.  The  gingival  ﬂap  is  then  reclined  to  ensure  good
isibility  of  the  anterior  surface  of  the  sinus  and  allow  the
ealization  of  a  bone  window  whose  upper  limit  is  15  mm
rom  the  crest.  The  bone  window  is  done  with  a  diamond
ound  bur  under  irrigation  (Fig.  4A).  The  central  trapdoor
f  cortical  bone  is  preserved  to  maintain  a  bone  layer  for
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the  mucosa  during  the  other  surgical  steps.  The  sinus  mem-
brane  is  then  gently  raised  from  the  bone  ﬂoor  to  delimit  a
sufﬁcient  volume.  At  this  stage,  one  should  carefully  check
the  presence  of  any  perforation  of  the  membrane  because
they  can  lead  to  complications  at  the  time  of  placement
of  the  biomaterial  (Fig.  4B).  A  suture  may  be  done  with  a
6/0  thread  or  a  -TCP  plate  (Sinus-upTM,  Kasios,  France)  to
ensure  a  complete  closure  of  the  sinus.  The  cavity  is  then
ﬁlled  with  a  biomaterial  that  will  latter  provide  the  bony  bed
suitable  for  implant  placement.  Autogenous  bone  chips  have
long  been  considered  as  the  gold  standard  due  to  their  pre-
sumptive  maintenance  of  cellular  viability  [12].  The  choice
of  a  biomaterial  must  fulﬁll  several  qualities:  it  should  be
biocompatible  in  the  grafted  site  and  should  not  induce
an  inﬂammatory  reaction  of  the  sinus  mucosa,  which  could
be  deleterious  to  the  whole  surgical  procedure.  It  must  be
integrated  within  the  grafted  areas  by  combining  its  resorp-
tion  and  its  substitution  by  new  bone.  Resorption  should
be  progressive  to  allow  bone  remodeling  with  apposition
of  lamellar  bone.  Non-resorbable  hydroxyapatite  should  be
avoided  [16].  Macroporosity  of  the  grafted  biomaterial  plays
a  key  role  in  bone  osteoconduction  because  it  determines
the  invasion  of  vascular  and  cellular  sprouts  [17,18].  Lastly,
the  grafting  material  must  be  provided  in  sufﬁcient  volume
to  allow  an  easy  adaptation  in  these  complex  surgical  areas
to  ﬁll  volumes  up  3  to  6  cm3.  Over  the  years,  several  types
of  materials  including  allografts  and  xenografts  of  various
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Figure  6  Lower  alveolar  nerve  (IAN)  lateralization.  A.  X-ray  of  a
large bone  defect.  B.  A  signiﬁcant  bone  defect  is  obtained  and  the  em
(-TCP) granules  (1000—2000  m)  with  a  high  porosity  are  used  to  ﬁ
IAN and  placement  of  four  implants  is  now  possible.117
rigins  have  been  used  either  alone  or  mixed  with  morcel-
ized  autogenic  bone  [19].  -tricalcium  phosphate  was  the
rst  synthetic  bone  substitute  to  be  proposed  for  sinus  ﬂoor
levation  [14].  The  use  of  1000—2000  m  granules  of  high
orosity  -TCP  HP  is  recommended  nowadays  [20].  Anthral
lling  begins  by  placing  granules  on  the  posterior  wall  then
n  the  latero-anterior  and  anteroposterior  walls  without
xcessive  compression  of  the  biomaterial  (Fig.  4C).  The
nterior  wall  is  then  ﬁlled  and  a  resorbable  SurgicelTM mem-
rane  (Ethicon,  Johnson  and  Johnson)  to  avoid  migration
f  granules  and  sutured  with  Vicryl  5/0TM thread  (Ethicon,
ohnson  and  Johnson).  A  computed  tomographic  analysis  is
sually  done  8  months  later.  There  is  a  marked  densiﬁcation
f  the  grafted  area  ﬁlled  by  the  biomaterial  and  no  edema
f  the  sinus  membrane  can  be  evidenced  (Fig.  4D).
The  grafted  area  appears  to  be  more  radio-opaque  than
he  surround  bone  tissue  (due  to  the  greater  calcium  content
f  -TCP).  The  density  will  progressively  decrease  as  the
iomaterial  is  replaced  by  bone  [21].  Histological  analysis
onﬁrmed  the  direct  bonding  of  mineralized  bone  matrix
o  -TCP  granules  together  with  the  biomaterial  resorption
Fig.  5A)  [10,22,23].  Depending  on  the  area,  the  bone  has  a
atrix  of  lamellar  or  non-lamellar  texture.  The  detection  of key  enzyme  present  in  the  osteoclasts  (tartrate  resistant
cid  phosphatase  [TRAcP])  evidences  these  cells  at  the  sur-
ace  of  the  newly  formed  bone  and  at  the  surface  of  -TCP
ranules  (Fig.  5B).
 patient  with  an  included  canine  whose  ablation  will  create  a
ergence  of  the  IAN  is  evidenced.  C.  Beta-tricalcium  phosphate
ll  this  area.  D.  X-ray  of  the  patient  after  lateralization  of  the
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ateralization  of  the  inferior  alveolar  nerve  (IAN)
ertical  atrophy  of  alveolar  ridge  is  encountered  at  the
andible  as  a  sequela  of  dental  extractions  (Fig.  6A)  or  in
atients  with  a  long  history  of  wearing  a  removable  pros-
hesis.  An  onlay  graft  allows  bone  reconstruction  in  the
ertical  direction  but  requires  the  use  autologous  cortico-
rabecular  bone  harvested  at  the  calvarium,  iliac  crest,
ibia  or  mandibular  symphysis,  retromolar  area,  mandibular
amus  [24].  The  use  of  allogenic  or  xenogenic  bone  par-
icles  has  also  been  suggested.  In  all  cases,  the  graft  is
aintained  to  the  alveolar  ridge  by  osteosynthesis  using  tita-
ium  screws.  The  IAN  remains  one  of  the  main  anatomical
imitation  to  the  placement  of  implants  in  the  poste-
ior  mandibular  zone.  Another  alternative  is  to  move  the
AN  laterally  from  its  canal  by  nerve  lateralization  and
epositioning  to  provide  a  bone  area  suitable  for  implant
lacement  [25].  The  displacement  of  the  IAN  can  be  pro-
osed  in  several  situations:  in  case  of  compression  of  the
erve  sheath  following  a  trauma,  when  a  removable  prosthe-
is  exerts  compressive  strains  on  the  IAN  or  when  an  implant
pex  directly  compresses  the  nerve  [7,11,26].  Lateraliza-
ion  of  the  IAN  radically  changes  the  nature  of  the  prosthetic
oncept  where  only  the  anterior  region  is  usually  concerned.
isplacement  of  the  nerve  allows  the  placement  of  implants
n  the  posterior  zone  with  a  removable  prosthesis  with  an  O-
ing  system  or  a  posterior  bar.  In  ﬁxed  dental  prosthesis,  the
osterior  implants  increase  the  holding  of  an  overdenture
r  a  ﬁxed  bridge  by  providing  supporting  pillars.  In  case  of  a
emovable  prosthesis,  attachment  of  the  prosthesis  is  con-
iderably  improved  when  an  O-ring  system  or  a  posterior  bar
s  used.
The  surgical  technique  is  based  on  a  vestibular  osteotomy
f  the  external  cortical  bone  in  front  of  the  mental  fora-
en,  and  extended  by  fashioning  of  a  bone  ﬂap  towards  the
ear  [27—29].  The  cortico-trabecular  bone  block  is  removed
o  gain  access  to  the  nerve  and  to  gently  tease  it  out  of
he  mandible  (Fig.  6B).  The  bone  block  is  both  removed
n  toto  or  morcellized  and  kept  until  the  end  of  the  inter-
ention.  Replacement  of  the  bony  ﬂap  allows  an  underlying
one  growth  and  prevents  the  nerve  from  returning  to  the
andibular  canal.  Nevertheless,  displacement  of  the  IAN
reates  a  bone  void.  It  can  be  ﬁlled  with  -TCP  particles
Fig.  6C)  held  in  place  with  a  SurgicelTM membrane.  Compact
locks  of  -TCP  can  also  be  implanted.  After  an  8-month
one  healing  period,  the  mandibular  bone  has  been  recon-
tituted  and  offers  a  suitable  site  for  implant  placement
Fig.  6D).  High  porosity  -TCP  granules  plays  an  essential
ole  in  the  local  remodeling  of  bone  volume  and  lead  to  the
ormation  of  a  quality  site.
onclusion
one  remodeling  is  an  essential  step  in  the  healing  process
f  a  grafted  area.  The  contribution  of  synthetic  biomaterials
s  now  conﬁrmed  and  guarantees  an  optimal  reconstruc-
ion  that  allows  implant  placement  in  a  second  step.  The
vailability  of  -TCP  in  the  form  of  granules  or  compact
labs  offers  new  therapeutic  perspectives  in  maxillofacial
nd  pre-implant  surgery.
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